Should You Buy Bitcoin in 2024? [Expert's Shocking Answer]

Bitcoin minted 100,000 millionaires and if you're not one of them, that ship has sailed. But there's another millionaire-minting crypto at our doorstep... research shows this coin could be 20X bigger than Bitcoin by the end of the decade. With crypto starting to heat up again, this could be the perfect time to get in.

Radical Change Inside American Banks

Popular

Bernie Sanders wants the US to adopt a 32-hour workweek. Could workers and companies benefit?

The 40-hour workweek has been standard in the U.S. for more than eight decades. Now some members of Congress want to give hourly workers an extra day off.

Crypto Pioneer: Do Not Listen to These So-Called Experts - Ad

Bitcoin's haters are out again. Despite the price doubling in the last six months alone...that hasn't stopped the experts from piling on. If you want to make game-changing money on this crypto bull market...There are five coins you must take a look at right away.

Ground cinnamon sold at discount stores is tainted with lead, FDA warns

Ground cinnamon sold by U.S. discount retailers is contaminated with high levels of lead and should be discarded, .

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, .

"Safe" Investors Who Don't Get Out of Cash NOW Could Lose Everything Over the Next Six Months - Ad

The next six months are going to be some of the most precarious times to invest in the history of the United States. Because for the first time, your money is at risk of being completely wiped out, even when you think it is safest. This bubble is on a schedule and to get out before your portfolio becomes shark bait, you need to...

What's Going On With Abbott Laboratories Stock On Friday?

An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about NEC risks. Over 400 NEC lawsuits pending in federal court in Chicago.

EPA tightens limits on a chemical used to sterilize medical equipment, citing cancer risk

WASHINGTON (AP) — The Environmental Protection Agency is imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes.

MUST SEE By March 20: Beware Biden's Trojan Horse - Ad

It could usher in the most radical transformation of our money we've ever seen in America's history... trigger a surprise election outcome in the coming months... and fundamentally alter the value of your savings forever. One 24-year market veteran warns that most Americans simply aren't prepared for what's coming on March 20.

FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers

Join the FDA's Oncologic Drugs Advisory Committee on March 15th to review Johnson & Johnson/Legend Biotech's Carvykti application for relapsed/refractory multiple myeloma treatment. Delve into CARTITUDE-4 results & risk-benefit assessment for cilta-cel. Updates on Abecma application by Bristol-Myers Squibb.

U.S. airport nasal swabbing expanding to Chicago and Miami

NEW YORK (AP) — The nation's top public health agency is expanding a program that tests international travelers for COVID-19 and other infectious diseases.

The Crypto Melt-up Has Begun - Ad

This crypto bull market is on the verge of a full-on panic. But not the kind that crashes prices. Instead, this appears to be a Melt-Up that drives Bitcoin and other cryptos into the stratosphere. Now, I've found a set of smaller cryptos that I think are going to soar in this crypto Melt-Up.

Europe is not prepared for the growing climate extremes it faces, its first risk assessment finds

Europe is facing growing climate risks and is unprepared for them, the European Environment Agency said in its first-ever risk assessment for the bloc Monday.

Biden is issuing a budget plan that details his vision for a second term

WASHINGTON (AP) — is issuing a budget plan Monday aimed at getting voters' attention: tax breaks for families, lower health care costs, smaller deficits and higher taxes on the wealthy and corporations.

CRITICAL March 20th Warning - Ad

Jason Bodner is going public today with an urgent new warning. He believes the most popular investment of 2024 is set to pop... And it could all start just days from now. This has NOTHING to do with A.I. stocks... It has NOTHING to do with crypto currency... And it has NOTHING to do with high-flying tech stocks. Instead, this corner of the market you likely have cash parked in has swelled to nearly $6 trillion.

FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug

INDIANAPOLIS (AP) — Federal regulators put off a decision on whether to approve an Eli Lilly Alzheimer’s drug by making an unusual request to have outside advisers look at the treatment.

$1k/Day in Crypto - Witness the Proven Strategy Now - Ad

Ever heard of those rare, almost mythical 100x, 200x or even 300x+ returns in the crypto world? Usually, they're the stuff of luck, hinging on choosing the right altcoin at the perfect moment. But what if there was a systematic, predictable way to achieve outsized returns in crypto?

Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?

Interim results from the Phase 1 trial of ALG.APV-527 by Alligator Bioscience and Aptevo Therapeutics. Positive signs of clinical activity in breast cancer patients, with well-tolerated treatment and ongoing dose escalation.

Novo Nordisk's Stock Hits 52-Week High After Highly Sought After Obesity Drug Trial Data

Explore Novo Nordisk's Capital Markets Day insights! Uncover early trial success of amycretin, a potential obesity drug, with 13.1% weight loss in Phase 1. Learn about its safety and upcoming Phase 2 trial.

Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad

Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.

South Korea's president vows not to tolerate walkouts by junior doctors

SEOUL, South Korea (AP) — South Korea's president vowed Wednesday not to tolerate the , calling them “an illegal collective action” that threatens public health and shakes the country’s governing systems.

America's Cash Bubble Set to Burst on March 20, 2024 - Ad

For the first time I've ever heard of... we know the exact day (and time) a bubble is going to burst. This is insane and something we only have access to because of Jason's findings (that he's sharing with his ultra-elite clients). To find out what the cash bubble is and why you're vulnerable to it without even realizing...

Millennial Money: 5 financial mistakes to avoid when you are self-employed

When you become self-employed, you join millions of other business owners hoping to materialize their dreams. However, navigating the murky waters of self-employment can be challenging, especially during the early stages.

Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why

Cellectar Biosciences reports positive Phase 1 trial results for iopofosine I 131 in head and neck squamous cell carcinoma, achieving 64% complete remission and 73% overall response rate. Roth Capital notes the drug's potential across various diseases, positioning CLRB as an attractive acquisition target.

On Location at My No. 1 A.I. Stock Pick - Ad

In this video, I go on location to share the name, ticker symbol, and story behind my #1 A.I. stock pick. I can almost guarantee you've never heard of this company -- but soon you, your friends, and your family will likely all be using it.

What's next for South Korean doctors who face license suspensions because of walkouts

SEOUL, South Korea (AP) — South Korea’s government is pressing ahead with its vow to of thousands of junior doctors who ignore its repeated demands to end their

Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic

NEW YORK (AP) — More than 61,000 pounds of steamed chicken soup dumplings sold at Trader Joe's are being recalled for possibly containing hard plastic, U.S. regulators announced Saturday.

The No. 1 AI Stock of 2024 (Not Nvidia) - Ad

It's not Nvidia, Meta Platforms, Alphabet, or Amazon. But thanks to a recent major deal, an under-the-radar stock could become the No. 1 winner of the AI boom. "This company just teamed up with one of the biggest power players in the AI industry... yet you can still buy it for just one-twelfth the price of Nvidia -- the time to buy is NOW," says Marc Chaikin.

Mistrial declared in Delaware lawsuit blaming landscaper's cancer on use of Roundup weedkiller

DOVER, Del. (AP) — A Delaware judge declared a mistrial Friday in the latest lawsuit alleging that exposure to the popular weedkiller Roundup causes cancer.

CVS and Walgreens plan to start dispensing abortion pill mifepristone soon

The drugstore chains CVS Health and Walgreens plan to start dispensing an pill in a few states within weeks.

His System Isolated Nvidia -- Here's His NEXT Buy - Ad

Marc Chaikin's stock-picking system isolated Nvidia before its massive bull run this year. Now, it just flashed "BUY" on a new AI company that no one is talking about yet. It's not a household name... but Marc predicts it could quickly double or triple from here.

A large US health care tech company was hacked. It's leading to billing delays and security concerns

Health care providers across the country are reeling from a cyberattack on a massive U.S. health care technology company that has threatened the security of patients’ information and is delaying some prescriptions and paychecks for medical workers.

Aid groups appeal to the European Union to release urgent funds for Palestinian refugee agency UNRWA

BRUSSELS (AP) — Humanitarian aid groups appealed on Thursday to the European Union to release tens of millions of euros in funding due to the main U.N. agency that delivers most aid to people in as the organization teeters on the brink of financial collapse.

Man Who Called $3 Trillion Apple Predicts the Next Trillion Dollar Stock - Ad

In 2007, he predicted Facebook would become a $100B company.... In 2010, he predicted Apple would reach a three-trillion-dollar valuation.... In 2013, he called Bitcoin -- before it rose 50,000% and ultimately reached a trillion-dollar market cap. And now... This A.I. Genius is stepping into the spotlight to predict the next-trillion stock.

Animal Health And Dental Equipment Challenges Bite As Patterson Companies Cuts Annual Guidance, Reports Mixed Q3 Earnings

Patterson Companies reports Q3 2024 net sales of $1.62 billion. Dental segment sales reach $637.1 million. Animal Health segment sales at $967.3 million, facing challenges in companion animal business. Revised FY 2024 citing headwinds in dental equipment market and broader economic challenges.

Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs

Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and pivotal data on obesity, inflammation, oncology, and rare diseases.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service